Tyrosinemia type I: clinical and biochemical analysis of patients in Mexico

Tyrosinemia type I: clinical and biochemical analysis of patients in Mexico

Introduction. Hepatorenal tyrosinemia (HT1) is a treatable, inherited, metabolic disease characterized by progressive liver failure with pronounced coagulopathy. The aim of this study is to describe the clinical, biochemical, and histopathological findings in a group of Mexican HT1 patients and thei...

Full description

Bibliographic Details
Main Authors:	Cynthia Fernández-Lainez, Isabel Ibarra-González, Leticia Belmont-Martínez, Susana Monroy-Santoyo, Sara Guillén-López, Marcela Vela-Amieva
Format:	Article
Language:	English
Published:	Elsevier 2014-03-01
Series:	Annals of Hepatology
Subjects:	Inborn errors of metabolism Acute liver failure Liver cirrhosis Nitisinone Tyrosine
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119308907

Similar Items

Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant
by: Isabel Ibarra‐González, et al.
Published: (2019-12-01)

Type 1 tyrosinemia in Finland: a nationwide study
by: Linnea Äärelä, et al.
Published: (2020-10-01)

Diagnostic and Therapeutic Challenges of Hereditary Tyrosinemia Type 1 in Lebanon: A 12-Year Retrospective Review
by: Karim N. Daou, et al.
Published: (2021-08-01)

Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet
by: María Ignacia García, et al.
Published: (2017-06-01)

Treatment adherence in tyrosinemia type 1 patients
by: Domingo González-Lamuño, et al.
Published: (2021-06-01)

Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC‐QTOF‐MS
by: Andrew S. Davison, et al.
Published: (2019-07-01)

Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation
by: Haaike Colemonts-Vroninks, et al.
Published: (2021-12-01)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
by: Das AM
Published: (2017-07-01)

Tyrosinemia Type I and Reversible Neurogenic Crisis After a One-Month Interruption of Nitisinone
by: Havva Yazıcı, et al.
Published: (2018-03-01)

First Macedonian child with tyrosinemia type 1 successfully treated with nitisinone and report of a novel mutation in the FAH gene
by: Kostovski Aco, et al.
Published: (2017-01-01)

Clinical Features of 29 Patients with Hereditary Tyrosinemia I in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients
by: Ahmad, M.S.Z, et al.
Published: (2022)

Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1
by: Imad Dweikat, et al.
Published: (2021-03-01)

Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
by: Isabel Ibarra-González, et al.
Published: (2017-07-01)

Recommendations for the management of tyrosinaemia type 1
by: de Laet Corinne, et al.
Published: (2013-01-01)

Steatosis of indeterminate cause in a pediatric group: is it a primary mitochondrial hepatopathy?
by: Gustavo Henrique Silva, et al.

Evaluation of pre-symptomatic nitisinone treatment on long-term outcomes in Tyrosinemia type 1 patients: a systematic review
by: Julia Geppert, et al.
Published: (2017-09-01)

Acute liver failure in under two year-olds - are there markers of metabolic disease on admission?
by: Ana Brett, et al.
Published: (2013-09-01)

Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature
by: Lakshminarayan Ranganath, et al.
Published: (2021-09-01)

Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*)
by: Rita Quelhas da Costa, et al.
Published: (2021-07-01)

3. Biochemical analysis in patients of hepatitis and cirrhosis.
by: Dr. Asha Khubchandani, et al.
Published: (2020-12-01)

Clinical and biochemical spectrum of metabolic cardiomyopathy in Egyptian children
by: Almenabawy, N.M, et al.
Published: (2022)

Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path
by: Angelo Colucci, et al.
Published: (2021-08-01)

Liver transplantation in Yekaterinburg: the first experience
by: E. N. Bessonova, et al.
Published: (2018-08-01)

Liver transplantation in children with inborn errors of metabolism: 30 years experience in NSW, Australia
by: Noha Elserafy, et al.
Published: (2021-07-01)

Hepatic-Based Inborn Errors of Metabolism
by: Tormod Lund
Published: (2015-01-01)

Anaesthetic considerations for liver transplantation in propionic acidemia
by: Akila Rajakumar, et al.
Published: (2016-01-01)

Dysbiosis, Host Metabolism, and Non-communicable Diseases: Trialogue in the Inborn Errors of Metabolism
by: Chiara Montanari, et al.
Published: (2021-09-01)

Recent research on liver fibrosis and cirrhosis
by: LU Lungen
Published: (2013-05-01)

Obesity in the Liver Transplant Setting
by: Carlos Moctezuma-Velazquez, et al.
Published: (2019-10-01)

Dynamics of Clinical and Biochemical Parameters in Patients with Liver Cirrhosis Under the Influence of Complex Therapy with Ursodeoxycholic Acid
by: M.I. Shved, et al.
Published: (2013-11-01)

Mortality From Alcohol-Related Liver Cirrhosis in Mexico (2000–2017)
by: Myrna L. Yeverino-Gutiérrez, et al.
Published: (2020-10-01)

Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011
by: Nicolas Di Benedetto, et al.
Published: (2014-01-01)

Transjugular Liver Biopsy: Results of 97 Patients
by: Kemal Deniz, et al.
Published: (2012-06-01)

Abernethy malformation misdiagnosed as liver cirrhosis: a report of one case
by: LI Li
Published: (2014-09-01)

The clinical importance of biochemical bone markers in patients with alcoholic and viral liver cirrhosis
by: Ćulafić-Vojinović Violeta, et al.
Published: (2014-01-01)

Comorbidities and Outcome of Alcoholic and Non-Alcoholic Liver Cirrhosis in Taiwan: A Population-Based Study
by: Tzu-Wei Yang, et al.
Published: (2020-04-01)

Antiviral therapy of HCV-cirrhosis: case of sequential treatment and review of literature
by: Kakharman Yesmembetov, et al.
Published: (2018-03-01)

Liver Transplantation in a Myopathic Patient with Glycogen Storage Disease Type IIIa and Decompensated Cirrhosis
by: M Zobeiri
Published: (2017-10-01)

Hepatopulmonary syndrome: an update
by: Liana Gonçalves de Macêdo, et al.